Heliosafetm: a platform for the fast, label-free, automated evaluation of sterility
Ended Definitive Contract Awarded Last action
- Contract number
- HR001121C0178
- Awardee
-
Heliowave Technologies Inc. UEI F9T3KRMMEXM4
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $225,000
Award facts
- Opportunity
-
- Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Pre-Solicitation · HR001120S0019 · Posted Feb 12, 2020
- Contract value 100% obligated
- $225,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- College Station, TX, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $225,000 |
About this award
This is a $225,000 Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Heliowave Technologies LLC, a small disadvantaged business located in College Station, Texas. The contract is for the development of the HELIOSAFE platform, a system for the fast, label-free, and automated evaluation of sterility, which is directly relevant to DARPA's mission focus on chemical and biological defense capabilities. The contract was competitively sourced through DARPA's annual Broad Agency Announcement seeking SBIR proposals. Heliowave has also received a $1.75 million SBIR Phase II follow-on contract and a $466,950 project grant from the National Institute of Allergy and Infectious Diseases to further develop its microfluidic and impedance detection technologies for bioburden testing and sterility evaluation applications in biomanufacturing.
Quick answers
Who was awarded contract HR001121C0178?
HR001121C0178 was awarded to Heliowave Technologies Inc. by Defense Advanced Research Projects Agency (Department of Defense) on June 14, 2021.
How much is contract HR001121C0178 worth?
The government has obligated $225,000 on HR001121C0178.
Was contract HR001121C0178 competed?
The extent of competition for HR001121C0178 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award